Cite

HARVARD Citation

    Geard, N. et al. (2022). Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule. Human vaccines & immunotherapeutics. 18 (6), p. . [Online]. 
  
Back to record